Monitoring Selected National HIV Prevention and Care Objectives By Using HIV Surveillance Data United States and 6 Dependent Areas, 2020: Figures

Related Pages
All Figures
Report Contents

Figure 1. Status of CD4 and viral load reporting, by area of residence as of December 2021—United States and dependent areas

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Technical Notes for more information on areas with complete laboratory reporting.

Download and Share This Infographicimage icon

 

Figure 2. Stage of disease at HIV diagnosis during 2020 (COVID-19 pandemic) among persons aged ≥13 years—45 states and the District of Columbia

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.

Download and Share This Infographicimage icon

 

Figure 3. Stage of disease at HIV diagnosis during 2020 (COVID-19 pandemic) among persons aged ≥13 years, by selected characteristics—45 states and the District of Columbia

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

 

Figure 4. Linkage to HIV Medical Care Within 1 Month of HIV Diagnosis During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years, by Selected Characteristics—45 States and the District of Columbia

Note. Gray line indicates the overall percentage of persons linked to care within 1 month of diagnosis. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

 

Figure 5. Linkage to HIV Medical Care Within 1 Month of HIV Diagnosis During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years, by Area Of Residence—45 States and the District of Columbia

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Data for Maryland should be interpreted with caution due to incomplete reporting of case information to CDC during December 2021.

Download and Share This Infographicimage icon

 

Figure 6a. Receipt of HIV Medical Care and Viral Suppression During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years Living with Diagnosed HIV Infection, by Gender—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.

Download and Share This Infographicimage icon

 

Figure 6b. Receipt of HIV Medical Care and Viral Suppression During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years Living with Diagnosed HIV Infection, by Age Group—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for Maryland should be interpreted with caution due to incomplete reporting of case information to CDC during December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.

Download and Share This Infographicimage icon

 

Figure 7a. Receipt of HIV Medical Care and Viral Suppression During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years Living with Diagnosed HIV Infection, by Race/Ethnicity—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Includes Asian/Pacific Islander legacy cases.
b Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

 

Figure 7b. Receipt of HIV Medical Care and Viral Suppression During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years Living with Diagnosed HIV Infection, by Transmission Category—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.

Download and Share This Infographicimage icon

Figure 8. Receipt of HIV Medical Care During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years Living with Diagnosed HIV Infection, by Area Of Residence—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. Data for Maryland should be interpreted with caution due to incomplete reporting of case information to CDC during December See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.

Download and Share This Infographicimage icon

 

Figure 9. Viral Suppression During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years Living with Diagnosed HIV Infection, by Area Of Residence—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for Maryland should be interpreted with caution due to incomplete reporting of case information to CDC during December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.

Download and Share This Infographicimage icon

 

Figure 10. Viral Suppression During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years Living with Diagnosed HIV Infection, by Selected Characteristics—45 States and the District of Columbia

Note. Gray line indicates overall percentage of persons who had viral suppression at the most recent viral load test. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Includes Asian/Pacific Islander legacy cases.
b Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

 

Figure 11. Stage 3 (AIDS) at Time of Diagnosis of HIV Infection During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years, by Area of Residence—United States

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.

Download and Share This Infographicimage icon

 

Figure 12. PrEP Coverage During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 16 Years, by Selected Characteristics—United States and Puerto Rico

Note. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Hispanic/Latino persons can be of any race.
b Includes American Indian/Alaska Native, Asian, Native Hawaiian/other Pacific Islander, and multiracial persons.

Download and Share This Infographicimage icon

 

Figure 13. PrEP Coverage During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 16 Years, by Area of Residence—United States and Puerto Rico

Note. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.

Download and Share This Infographicimage icon

 

Figure 14. Linkage to HIV Medical Care Within 1 Month and Viral Suppression Within 6 Months of HIV Diagnosis During 2020 (COVID-19 Pandemic) Among Men Who Have Sex With Men (Sex Assigned at Birth), by Race/Ethnicity—45 States and the District of Columbia

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

 

Figure 15. Receipt of HIV Medical Care and Viral Suppression During 2020 (COVID-19 Pandemic) Among Men Who Have Sex with Men (Sex Assigned at Birth), by Race/Ethnicity—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Includes Asian/Pacific Islander legacy cases.
b Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

Figure 16. Earlier and Late Stage of Disease At HIV Diagnosis During 2020 (COVID-19 Pandemic) Among Persons Who Inject Drugs, by Sex Assigned at Birth and Race/Ethnicity—45 States and the District of Columbia

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications. Diagnosis of HIV infection may not be reported for some groups in 2020.
a Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

Figure 17. Linkage to HIV Medical Care Within 1 Month and Viral Suppression Within 6 Months of HIV Diagnosis During 2020 (COVID-19 Pandemic) Among Persons Who Inject Drugs, by Sex Assigned at Birth and Race/Ethnicity—45 States and the District of Columbia

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications. Diagnosis of HIV infection may not be reported for some groups in 2020.
a Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

Figure 17b. Linkage to HIV Medical Care Within 1 Month and Viral Suppression Within 6 Months of HIV Diagnosis During 2020 (COVID-19 Pandemic) Among Persons Who Inject Drugs, by Sex Assigned at Birth and Race/Ethnicity—45 States and the District of Columbia

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications. Diagnosis of HIV infection may not be reported for some groups in 2020.
a Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

 

Figure 18. Receipt of HIV Medical Care and Viral Suppression During 2020 (COVID-19 Pandemic) Among Persons Who Inject Drugs, by Sex Assigned at Birth and Race/Ethnicity—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Includes Asian/Pacific Islander legacy cases.
b Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

Figure 19. Receipt of HIV Medical Care And Viral Suppression During 2020 (COVID-19 Pandemic) Among Transgender And Additional Gender Identity Persons—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.

Download and Share This Infographicimage icon

 

Figure 20. Earlier and Late Stage of Disease at HIV Diagnosis During 2020 (COVID-19 Pandemic) Among Women (Sex Assigned at Birth), by Race/Ethnicity—45 States and the District of Columbia

Note. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

 

Figure 21. Receipt of HIV Medical Care and Viral Suppression During 2020 (COVID-19 Pandemic) Among Women (Sex Assigned at Birth), by Race/Ethnicity—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Includes Asian/Pacific Islander legacy cases.
b Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

 

Figure 22. Perinatally Acquired HIV Infection Among Persons Born in the United States, by Year of Birth and Mother’s Race/Ethnicity, 2016–2020—United States

Note. Live-birth data reflect race/ethnicity of the infant’s mother. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Hispanic/Latino persons can be of any race.
b Includes American Indian/Alaska Native, Asian, Native Hawaiian/other Pacific Islander, and multiracial persons

Download and Share This Infographicimage icon

 

Figure 23. Receipt of HIV Medical Care and Viral Suppression During 2020 (COVID-19 Pandemic) Among Young Persons Aged 13–24 Years, by Sex Assigned at Birth and Race/Ethnicity—45 States and the District of Columbia

Note. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should also be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Includes Asian/Pacific Islander legacy cases.
b Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

Figure 24. Status of Linkage to HIV Medical Care Within 1 Month of HIV Diagnosis During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years, vy Selected Characteristics—45 States and the District of Columbia

Note. Gray line indicates the overall percentage of persons linked to care within 1 month of diagnosis. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

Figure 25. Status of Viral Suppression During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 13 Years Living with Diagnosed HIV Infection, by Selected Characteristics—45 States and District of Columbia

Note. Gray line indicates the overall percentage of persons had viral suppression at the most recent viral load test. Data for the year 2020 are preliminary and based on deaths reported to CDC as of December 2021. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Hispanic/Latino persons can be of any race.

Download and Share This Infographicimage icon

Figure 26. Status of PrEP Coverage During 2020 (COVID-19 Pandemic) Among Persons Aged ≥ 16 Years, by Race/Ethnicity and Sex Assigned at Birth—United States and Puerto Rico

Note. Gray line indicates the overall percentage of persons with indications for PrEP prescribed PrEP. Data for 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities in state/local jurisdictions. See Guide to Acronyms and Initialisms, Data Tables, and Technical Notes for more information on definitions and data specifications.
a Hispanic/Latino persons can be of any race.
b Includes American Indian/Alaska Native, Asian, Native Hawaiian/other Pacific Islander, and multiracial persons.

Download and Share This Infographicimage icon

Top of Page
View Page In:pdf icon Monitoring Selected National HIV Prevention and Care Objectives By Using HIV Surveillance Data United States and 6 Dependent Areas, 2020
Page last reviewed: May 24, 2022
Content source: Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention